Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

In the year 2024, Castle Biosciences had annual revenue of $332.07M with 51.09% growth. Castle Biosciences had revenue of $86.31M in the quarter ending December 31, 2024, with 30.54% growth.

• Revenue (ttm): $332.07M
• Revenue Growth: +51.09%
• P/S Ratio: 1.78
• Revenue / Employee: $436,359
• Employees: 761
• Market Cap: 615.98M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.07M	112.28M	51.09%
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.